Výsledky vyhledávání - Ryo Nishikawa
- Zobrazuji výsledky 1 - 20 z 62
- Přejít na další stránku
-
1
Standard Therapy for Glioblastoma- A Review of Where We Are Autor Ryo Nishikawa
Vydáno 2010Revisão -
2
-
3
-
4
-
5
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study Autor Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori
Vydáno 2023Artigo -
6
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy Autor Frank Saran, Olivier Chinot, Roger Henriksson, Warren Mason, Wolfgang Wick, Timothy F. Cloughesy, Sunita Dhar, Emanuela Pozzi, Josep Garcia, Ryo Nishikawa
Vydáno 2016Artigo -
7
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma Autor Wolfgang Wick, Olivier Chinot, Martin Bendszus, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Cédric Révil, Yannick Kerloëguen, Timothy F. Cloughesy
Vydáno 2016Artigo -
8
Prognostic Impact of No-Flow Time on 30-Day Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Who Received Extracorporeal Cardiopulmonary Resuscitation Autor Naoto Murakami, Nobuaki Kokubu, Nobutaka Nagano, Jun‐ichi Nishida, Ryo Nishikawa, Jun Nakata, Yohei Suzuki, Kazufumi Tsuchihashi, Eichi Narimatsu, Tetsuji Miura
Vydáno 2020Artigo -
9
Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma Autor Ping Guo, Yorihisa Imanishi, Frank C. Cackowski, Michael J. Jarzynka, Huo-Quan Tao, Ryo Nishikawa, Takanori Hirose, Bo Hu, Shi‐Yuan Cheng
Vydáno 2005Artigo -
10
Significance of <i>IDH</i> mutations varies with tumor histology, grade, and genetics in Japanese glioma patients Autor Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito
Vydáno 2011Artigo -
11
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio Autor Olivier Chinot, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Timothy F. Cloughesy, Josep Garcia, Cédric Révil, Lauren E. Abrey, Wolfgang Wick
Vydáno 2016Artigo -
12
Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway Autor Bo Hu, Ping Guo, Ifat Bar-Joseph, Yorihisa Imanishi, Michael J. Jarzynka, Oliver Bögler, Tom Mikkelsen, Takanori Hirose, Ryo Nishikawa, Shi‐Yuan Cheng
Vydáno 2007Artigo -
13
Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts Autor Hirokazu Takami, Avital Perry, Christopher S. Graffeo, Caterina Giannini, Yoshitaka Narita, Yoichi Nakazato, Nobuhito Saito, Ryo Nishikawa, Masao Matsutani, Koichi Ichimura, David J. Daniels
Vydáno 2020Artigo -
14
Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma Autor Motoo Nagane, Ryo Nishikawa, Yusuke Narita, H. Kobayashi, Shingo Takano, Nobusada Shinoura, Taku Aoki, Keiji Sugiyama, J. Kuratsu, Yoshihiro Muragaki, Yasuo Sawamura, Masao Matsutani
Vydáno 2012Artigo -
15
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma Autor Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Vydáno 2024Artigo -
16
Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancer Autor Reika Iwakawa, Masataka Takenaka, Takashi Kohno, Yoko Shimada, Yasushi Totoki, Tatsuhiro Shibata, Koji Tsuta, Ryo Nishikawa, Masayuki Noguchi, Aiko Sato‐Otsubo, Seishi Ogawa, Jun Yokota
Vydáno 2013Artigo -
17
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans Autor Kun-Wei Liu, Haizhong Feng, Robert Bachoo, Andrius Kazlauskas, Erin Smith, Karen Symes, Ronald L. Hamilton, Motoo Nagane, Ryo Nishikawa, Bo Hu, Shi-Yuan Cheng
Vydáno 2011Artigo -
18
The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and... Autor Hongyi Huang, Motoo Nagane, Candice K. Klingbeil, Hong Lin, Ryo Nishikawa, Xiang-Dong Ji, Chun‐Ming Huang, Gordon N. Gill, H Wiley, Webster K. Cavenee
Vydáno 1997Artigo -
19
ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion Autor Michael J. Jarzynka, Bo Hu, Kwok-Min Hui, Ifat Bar-Joseph, Weisong Gu, Takanori Hirose, Lisa B. Haney, Kodi S. Ravichandran, Ryo Nishikawa, Shi‐Yuan Cheng
Vydáno 2007Artigo -
20
Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images Autor Hitoshi Tabuchi, Justin Engelmann, Fumiatsu Maeda, Ryo Nishikawa, Toshihiko Nagasawa, Tomofusa Yamauchi, Mao Tanabe, Masahiro Akada, Keita Kihara, Yasuyuki Nakae, Yoshiaki Kiuchi, Miguel O. Bernabéu
Vydáno 2024Artigo
Vyhledávací nástroje:
Související témata
Medicine
Cancer research
Internal medicine
Biology
Gene
Genetics
Pathology
Oncology
Chemotherapy
Glioma
Cancer
Biochemistry
Radiation therapy
Cell biology
Temozolomide
Confidence interval
Hazard ratio
Signal transduction
Surgery
Bevacizumab
Glioblastoma
Mutation
IDH1
Adverse effect
Alternative medicine
Chemistry
Clinical trial
Computer science
Placebo
Progression-free survival